Candida africana sp. nov., a new human pathogen or a variant of Candida albicans?

Mycoses. 2001 Dec;44(11-12):437-45. doi: 10.1046/j.1439-0507.2001.00707.x.

Abstract

Atypical Candida strains were isolated from patients in Madagascar, Angola and Germany. These isolates were slow growing and were unable to produce chlamydospores. They had atypical carbohydrate assimilation profiles. All strains were unable to assimilate the amino sugars N-acteylglucosamine and glucosamine as well as the disaccharide trehalose and the organic acid DL-lactate. They were germ-tube-positive in serum, but only some of these organisms produced pseudohyphae after a long incubation. As shown by Fourier transform infrared spectroscopy the atypical Candida isolates clustered as a monophyletic group different from C. albicans and C. dubliniensis. All strains belonged to C. albicans serotype B. Considering all data presented here, this group of Candida strains differs from any other known member of the genus Candida. Therefore, it is suggested to represent a new species within the genus Candida for which the name Candida africana is proposed.

MeSH terms

  • Angola
  • Candida / classification*
  • Candida / metabolism
  • Candida / pathogenicity
  • Candidiasis / microbiology*
  • Carbohydrate Metabolism
  • Female
  • Germany
  • Humans
  • Madagascar
  • Male
  • Species Specificity